CANGIALOSI LORETTA V 4
4 · PFIZER INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
PFIZER INCPFE
CANGIALOSI LORETTA V
Sr. Vice President, Controller
Transactions
- Exercise/Conversion
Common Stock
2020-02-28$27.37/sh+27,422$750,540→ 140,744 total - Exercise/Conversion
Stock Appreciation Rights
2020-02-28−27,422→ 0 totalExercise: $27.37From: 2020-02-28Exp: 2020-02-28→ Common Stock (27,422 underlying) - Tax Payment
Common Stock
2020-02-28$36.45/sh−14,166$516,351→ 122,075 total - Tax Payment
Common Stock
2020-02-28$33.42/sh−4,503$150,490→ 136,241 total
Holdings
- 2,686(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.